Perspectives in Designing Multifunctional Molecules in Antipsychotic Drug Discovery.

about

Revisiting the Therapeutic Potential of Bothrops jararaca Venom: Screening for Novel Activities Using Connectivity Mapping.

P2860

Q48507956-0523F693-1ED0-4340-A0EF-459764ECE2E7

P2860

Perspectives in Designing Multifunctional Molecules in Antipsychotic Drug Discovery.

Item

http://www.wikidata.org/entity/Q38931450

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Perspectives in Designing Multifunctional Molecules in Antipsychotic Drug Discovery.

@en

type

Item

label

Perspectives in Designing Multifunctional Molecules in Antipsychotic Drug Discovery.

@en

prefLabel

Perspectives in Designing Multifunctional Molecules in Antipsychotic Drug Discovery.

@en

P1476

Perspectives in Designing Multifunctional Molecules in Antipsychotic Drug Discovery.

@en

P2093

Andrea Milelli

http://www.w3.org/2001/XMLSchema#string

Carmela Fimognari

http://www.w3.org/2001/XMLSchema#string

Eleonora Turrini

http://www.w3.org/2001/XMLSchema#string

Francesca Maffei

http://www.w3.org/2001/XMLSchema#string

P2860

SSRI Antidepressant Medications: Adverse Effects and Tolerability

Vilazodone for the Treatment of Depression: An Update

Navigating the Chemical Space of Multitarget-Directed Ligands: From Hybrids to Fragments in Alzheimer's Disease

ACS chemical neuroscience molecule spotlight on Potiga (Ezogabine)

Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia

Dual- and triple-acting agents for treating core and co-morbid symptoms of major depression: novel concepts, new drugs

From single target to multitarget/network therapeutics in Alzheimer's therapy

New 3-[4-(aryl)piperazin-1-yl]-1-(benzo[b]thiophen-3-yl)propane derivatives with dual action at 5-HT1A serotonin receptors and serotonin transporter as a new class of antidepressants.

The dual transporter inhibitor duloxetine: a review of its preclinical pharmacology, pharmacokinetic profile, and clinical results in depression.

Inhibition of serotonin and norepinephrine reuptake and inhibition of phosphodiesterase by multi-target inhibitors as potential agents for depression.

P304

437-443

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/DDR.21334

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Elena Catanzaro

P577

2016-08-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27539712

http://www.w3.org/2001/XMLSchema#string

Perspectives in Designing Multifunctional Molecules in Antipsychotic Drug Discovery.

about

P2860

P2860

Perspectives in Designing Multifunctional Molecules in Antipsychotic Drug Discovery.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698